Medios Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 50.00 K
as on 20-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.80 Cr
as on 20-12-2024
- Revenue -72.18%
(FY 2021)
- Profit -28.75%
(FY 2021)
- Ebitda -21.91%
(FY 2021)
- Net Worth 29.70%
(FY 2021)
- Total Assets -32.86%
(FY 2021)
About Medios Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹3.80 Cr.
Rohit Goyal and Sandeep Garg serve as directors at the Company.
- CIN/LLPIN
U51504HP2013PTC000481
- Company No.
000481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medios Laboratories Private Limited offer?
Medios Laboratories Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Cosmetics, Hair & Beauty Products, Body Care Products, Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Medios Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Goyal  | Director | 26-Jul-2013 | Current |
| Sandeep Garg | Director | 26-Jul-2013 | Current |
Financial Performance of Medios Laboratories.
Medios Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 72.18% decrease. The company also saw a substantial fall in profitability, with a 28.75% decrease in profit. The company's net worth Soared by an impressive increase of 29.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medios Laboratories?
In 2021, Medios Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 May 2022 | ₹3.80 Cr | Open |
How Many Employees Work at Medios Laboratories?
Unlock and access historical data on people associated with Medios Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medios Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medios Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
